Skip to content

Seizert Capital Partners, LLC 13F Holdings · Q2 2026

Seizert Capital Partners, LLC reported 181 securities worth $2.42B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: MTCH (3.29%), NTAP (3.06%), JPM (2.93%). Among its top 25 positions this quarter: 9 added, 16 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1MTCHMatch Group Inc$79.8M3.29%2.1MTrimmed
2NTAPNetApp Inc.$74.2M3.06%479,743Trimmed
3JPMJPMorgan Chase & Co.$71.0M2.93%216,882Trimmed
4CSCOCisco Systems, Inc.$70.2M2.90%597,558Trimmed
5QCOMQUALCOMM Inc.$66.4M2.74%359,592Trimmed
6GSGoldman Sachs Group, Inc.$66.2M2.73%65,492Trimmed
7BRKBBerkshire Hathaway Inc.$63.3M2.61%126,481Added
8EXPEExpedia Group Inc$63.1M2.61%246,631Trimmed
9SNASnap-On Incorporated$60.6M2.50%150,626Added
10GNTXGentex Corp$59.0M2.44%2.3MAdded
11ALSNAllison Transmission Holdings Inc$57.7M2.38%512,169Trimmed
12ZMZoom Communications Inc.$57.7M2.38%668,781Added
13LKQLKQ Corporation$56.9M2.35%2.2MTrimmed
14AYIAcuity Inc.$56.0M2.31%148,732Trimmed
15GOOGLAlphabet Inc.$55.2M2.28%154,567Trimmed
16WFCWells Fargo & Co.$53.5M2.21%647,464Trimmed
17PHMPulte Group Inc$52.2M2.16%380,746Added
18COFCapital One Financial Corp.$52.0M2.15%259,218Trimmed
19CIThe Cigna Group$51.8M2.14%188,036Added
20MASMasco Corporation$50.9M2.10%625,564Added
21ELVElevance Health Inc.$46.8M1.93%120,942Added
22NBIXNeurocrine Biosciences Inc$46.7M1.93%277,337Added
23UNHUnitedHealth Group Inc.$46.5M1.92%111,973Trimmed
24REGNRegeneron Pharmaceuticals, Inc.$44.4M1.83%71,169Trimmed
25CCKCrown Holdings Inc$43.8M1.81%391,820Trimmed

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR